Latest / Raleigh News Today | 2 Min News | The Daily News Now!
AstraZeneca’s Wainua Trial Fails | Raleigh News
AstraZeneca just suffered its biggest single-day market crash since 2020 after its heart drug Wainua failed a major late-stage trial—shaking investor confidence and leaving a gap in its pipeline. The drug, developed with Ionis, aimed to reduce heart-related deaths but fell short of its primary goal after 140 weeks. Competitors like BridgeBio and Alnylam saw stock gains as the field opened up. Analysts are questioning AstraZeneca’s trial reliability, especially given the promising early data. While the setback is serious, the company’s broader business remains intact, with investors watching…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.